TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28013329

Group type: EXPERIMENTAL
Intervention: Cisatracurium besylate (NMBA) continuous infusion for 48 hours in moderate ARDS patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no NMBA) in moderate ARDS patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cisatracurium besylate (NMBA) for severe ARDS patients (no randomization)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Driving pressure and delta P L (∆P L) related to NMBA administration
Number of subjects: 30
Study: 26505132

Group type: EXPERIMENTAL
Intervention: e.max CAD (Cerec AC system)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cercon (zirconia-based)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IPS e.max Press
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metal-ceramic restorations
Number of subjects: 40
Study: 24600657

Group type: EXPERIMENTAL
Intervention: Bovine bone mineral plus collagen membrane (test)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Spontaneous healing (control)
Number of subjects: 48
Study: 23018283

Group type: EXPERIMENTAL
Intervention: Clozapine suspension (50 mg/mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clozaril(®) tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clozapine suspension and Clozaril(®) tablets
Number of subjects: 0
Study: 20472916

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 156

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 18238728

Group type: EXPERIMENTAL
Intervention: Multifactorial falls-prevention program (Stand Up!)
Number of subjects: 10
Study: 16227551

Group type: EXPERIMENTAL
Intervention: MRI brain scan
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 150
Study: 12085247

Group type: EXPERIMENTAL
Intervention: Training group (communication skills training workshop)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 115
Study: 9928544

Group type: EXPERIMENTAL
Intervention: Estrogen/hormone replacement therapy (ERT/HRT)
Number of subjects: 0
Study: 8585289

Group type: EXPERIMENTAL
Intervention: Monovalent liposome‐adjuvanted vaccine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control subvirion vaccine
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Licensed trivalent subvirion vaccine (reimmunization after 18 weeks)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Young adults (control group for comparison)
Number of subjects: 77
Study: 2816237

Group type: EXPERIMENTAL
Intervention: Thiopentone 6 mg/kg as a rapid intravenous bolus during CPB
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thiopentone 6 mg/kg as a 15‐min intravenous infusion before CPB
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: In vitro binding of thiopentone to CPB equipment
Number of subjects: 30
Study: 29293362

Group type: EXPERIMENTAL
Intervention: Outside-In (OI) technique
Number of subjects: 128

Group type: COMPARATOR
Intervention: Transportal (TP) technique
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: KT-2000 arthrometer results
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Second-look arthroscopic findings
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: MRI findings
Number of subjects: 128
Study: 28969611

Group type: EXPERIMENTAL
Intervention: Web-based intervention consisting of 10 modules tailored to treatment type, relationship status, and sexual orientation.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study: 26309217

Group type: EXPERIMENTAL
Intervention: Angiopoietin 2 (Ang2) plasma levels
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: sTie2 plasma levels
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ang1 plasma levels
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Urinary levels of N-acetyl-beta-D-glucosaminidase (NAG)
Number of subjects: 21
Study: 23312680

Group type: EXPERIMENTAL
Intervention: Stretching exercises
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bedding pillow
Number of subjects: 50
Study: 22003405

Group type: EXPERIMENTAL
Intervention: Peginterferon (PEG) and weight-based ribavirin (WBR) therapy
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Pretreatment prediction score incorporating IL28B genotype and baseline HCV viral load
Number of subjects: 231
Study: 18352915

Group type: EXPERIMENTAL
Intervention: Pamphlets (P)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pamphlets + Lecture (P + L)
Number of subjects: 3

Group type: COMPARATOR
Intervention: No intervention/control (C)
Number of subjects: 3
Study: 17075906

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy combined with cognitive behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological agents
Number of subjects: 0
Study: 12846865

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10915231

Group type: EXPERIMENTAL
Intervention: Office blood pressure measurement
Number of subjects: 21

Group type: COMPARATOR
Intervention: Ambulatory blood pressure measurement
Number of subjects: 21

Group type: COMPARATOR
Intervention: Self-monitoring blood pressure measurement
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oscillometric wrist device
Number of subjects: 21
Study: 8986200

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 35
Study: 1456575

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: COMPARATOR
Intervention: Canister weight measurement
Number of subjects: 95

Group type: COMPARATOR
Intervention: Self-report
Number of subjects: 95

Group type: COMPARATOR
Intervention: Microprocessor monitoring (Nebulizer Chronolog)
Number of subjects: 95
Study: 6741668

Group type: EXPERIMENTAL
Intervention: High maintenance doses of methadone (Group 1) for a 14-week period
Number of subjects: 0

Group type: COMPARATOR
Intervention: No dose modifications (Group 2) during the same 14-week period
Number of subjects: 0
Study: 31013172

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 29754952

Group type: EXPERIMENTAL
Intervention: Early time-restricted feeding (eTRF) - 6-hour feeding period, dinner before 3 p.m.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schedule - 12-hour feeding period
Number of subjects: 0
Study: 27117285

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 25365892

Group type: EXPERIMENTAL
Intervention: Epidural low-dose morphine-soaked microfibrillar collagen sponge (MMCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural normal saline-soaked microfibrillar collagen sponge (placebo)
Number of subjects: 0
Study: 22812450

Group type: EXPERIMENTAL
Intervention: MRI measurements of the musculoskeletal system, brain and pain perception, cardiovascular system, body composition, oxidative stress and inflammation.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Daily urine samples, periodic blood samples, and electrocardiograms (ECG).
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) and anthropological measurements.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Psychological questionnaires.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall race performance metrics.
Number of subjects: 44
Study: 19570764

Group type: EXPERIMENTAL
Intervention: Sequential treatment with potassium canrenoate (200 mg/day, increased to 400 mg/day) and furosemide (50 mg/day, increased to 150 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined treatment with potassium canrenoate (200 mg/day, increased to 400 mg/day) and furosemide (50 mg/day, increased to 150 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sequential treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Combined treatment
Number of subjects: 100
Study: 17920481

Group type: EXPERIMENTAL
Intervention: Robotic-assisted implantation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional manual implantation
Number of subjects: 72
Study: 16343028

Group type: EXPERIMENTAL
Intervention: 20% azelaic acid
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0.5% anthralin
Number of subjects: 31
Study: 12213433

Group type: EXPERIMENTAL
Intervention: Carnitine treatment
Number of subjects: 24
Study: 10541084

Group type: EXPERIMENTAL
Intervention: Monitor display format
Number of subjects: 4

Group type: COMPARATOR
Intervention: Film display format
Number of subjects: 4
Study: 7848124

Group type: EXPERIMENTAL
Intervention: Cranial irradiation plus intrathecal methotrexate sodium
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intrathecal methotrexate alone
Number of subjects: 74
Study: 1983347

Group type: EXPERIMENTAL
Intervention: sufotidine 600 mg nocte
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: sufotidine 600 mg b.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 698177

Group type: EXPERIMENTAL
Intervention: Hemicellulose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Raffinose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cellulose
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pectin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lignin
Number of subjects: 8
Study: 31018210

Group type: EXPERIMENTAL
Intervention: Pleural cryobiopsy (CB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Flexible forceps biopsy (FFB)
Number of subjects: 50
Study: 28715907

Group type: EXPERIMENTAL
Intervention: Immediate prolonged exposure treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 66
Study: 26481666

Group type: EXPERIMENTAL
Intervention: Neural Gliding
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Neural Stretching
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 23222915

Group type: EXPERIMENTAL
Intervention: Once-daily tadalafil 5 mg for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21972857

Group type: EXPERIMENTAL
Intervention: MOVE program (4-session self-regulation curriculum)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 58
Study: 18077191

Group type: EXPERIMENTAL
Intervention: SR-EVR
Number of subjects: 65

Group type: COMPARATOR
Intervention: Open Aneurysm Repair (OR)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Colorectal Resection (CR)
Number of subjects: 65
Study: 15721417

Group type: EXPERIMENTAL
Intervention: RT + CT (cisplatin 70 mg/m2 plus fluorouracil 1000 mg/m2 every 3 weeks for four cycles)
Number of subjects: 243

Group type: COMPARATOR
Intervention: RT
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 243
Study: 12033095

Group type: EXPERIMENTAL
Intervention: Haemodilution (5.5-8 mL.kg-1 blood withdrawn before induction, replaced by colloids)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no haemodilution)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Haemodilution
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 10456309

Group type: EXPERIMENTAL
Intervention: Squatting position
Number of subjects: 240

Group type: COMPARATOR
Intervention: Lithotomy position
Number of subjects: 240
Study: 7799116

Group type: EXPERIMENTAL
Intervention: Ibuprofen and methylprednisolone
Number of subjects: 0
Study: 1971708

Group type: EXPERIMENTAL
Intervention: 150 mg of propafenone every eight hours for five days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 225 mg of propafenone every eight hours for five days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 300 mg of propafenone every eight hours for five days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 693750

Group type: EXPERIMENTAL
Intervention: Squeezing a dynamometer during stimulus presentations
Number of subjects: 20

Group type: COMPARATOR
Intervention: No dynamometer squeezing (control group)
Number of subjects: 20
Study: 31823812

Group type: EXPERIMENTAL
Intervention: eHealth plus standard of care (motivational interviewing plus tooth scaling and polishing)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard of care only (motivational interviewing plus tooth scaling and polishing)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 86
Study: 29200757

Group type: EXPERIMENTAL
Intervention: 1,064-nm Nd:YAG laser therapy and amorolfine nail lacquer
Number of subjects: 128

Group type: COMPARATOR
Intervention: Topical amorolfine lacquer monotherapy
Number of subjects: 128
Study: 26386748

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cognitive Behavior Therapy for Insomnia (CBT-I)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mindfulness facets (acting with awareness, non-judging, non-reacting)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both MBCR and CBT-I
Number of subjects: 72
Study: 24169300

Group type: EXPERIMENTAL
Intervention: The11 injury prevention program
Number of subjects: 456

Group type: COMPARATOR
Intervention: Usual warm-up routines (Control)
Number of subjects: 456
Study: 20574108

Group type: EXPERIMENTAL
Intervention: Real rTMS stimulation for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment for 2 weeks followed by 2 weeks of real rTMS stimulation
Number of subjects: 10
Study: 19204602

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise program (8-12 weeks ramp-up followed by 12 weeks of exercise, approximately 228 min/week at 40-60% peak VO2, n = 21)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (no change in lifestyle, n = 16)
Number of subjects: 37
Study: 17285234

Group type: EXPERIMENTAL
Intervention: Follow-up by general practitioners
Number of subjects: 338

Group type: COMPARATOR
Intervention: Follow-up by surgeons
Number of subjects: 338

Group type: COMPARATOR
Intervention: General population
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: General practitioners and surgeons
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Advanced Dukes stage
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Patient choice of follow-up setting
Number of subjects: 338
Study: 14625698

Group type: EXPERIMENTAL
Intervention: Lichtenstein repair (n=126)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Read‐Rives repair (n=121)
Number of subjects: 247
Study: 11176912

Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg once daily for 7 days
Number of subjects: 955

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study: 9589380

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (6 g, reduced to 3 g from day +30)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 42
Study: 8113551

Group type: EXPERIMENTAL
Intervention: Warfarin plus antiplatelet therapy
Number of subjects: 195

Group type: COMPARATOR
Intervention: Warfarin alone
Number of subjects: 195
Study: 3072969

Group type: EXPERIMENTAL
Intervention: SAAVE
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 29617058

Group type: EXPERIMENTAL
Intervention: EDX110
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study: 29184579

Group type: EXPERIMENTAL
Intervention: Peer support program (6 sessions, 1 hour each)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (2 sessions held by the researcher)
Number of subjects: 64
Study: 26345129

Group type: EXPERIMENTAL
Intervention: 1% flutamide cream
Number of subjects: 74

Group type: COMPARATOR
Intervention: 4% hydroquinone cream
Number of subjects: 74
Study: 24099334

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (remote exchange of vital signs and symptoms data)
Number of subjects: 3230

Group type: COMPARATOR
Intervention: Usual care (excluding telehealth)
Number of subjects: 3230

Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 3230

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3230
Study: 20308941

Group type: EXPERIMENTAL
Intervention: Printed information package containing guideline recommendations for the management of LBP (n = 876)
Number of subjects: 1758

Group type: COMPARATOR
Intervention: No intervention (n = 882)
Number of subjects: 1758
Study: 18407022

Group type: EXPERIMENTAL
Intervention: Visual computer program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Commercial information leaflet
Number of subjects: 80
Study: 15637977

Group type: EXPERIMENTAL
Intervention: Re-dosing regimen (2 doses at the start of brushing with 1 additional in-mouth dose during the last 30 seconds of brushing [2+1])
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional regimen (2 doses at the start of brushing only [2+0])
Number of subjects: 18
Study: 11561033

Group type: EXPERIMENTAL
Intervention: Lee Silverman voice treatment (LSVT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Respiratory therapy (RET)
Number of subjects: 33
Study: 9491946

Group type: EXPERIMENTAL
Intervention: Patients without critical coronary narrowing
Number of subjects: 64

Group type: COMPARATOR
Intervention: Patients with critical coronary narrowing
Number of subjects: 64
Study: 8018578

Group type: EXPERIMENTAL
Intervention: Chemotherapy regimen for small cell lung cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy regimen for non-small cell lung cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unadjusted comparisons of clinician experience
Number of subjects: 0
Study: 3364218

Group type: EXPERIMENTAL
Intervention: Smokeless tobacco use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 0
Study: 29094957

Group type: EXPERIMENTAL
Intervention: Early intervention group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 56
Study: 26799502

Group type: EXPERIMENTAL
Intervention: Behavioral parent training (BPT)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Maternal stimulant medication (MSM)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined BPT+MSM
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Full-scale SMART
Number of subjects: 26
Study: 24450367

Group type: EXPERIMENTAL
Intervention: Cervical manipulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thoracic manipulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonmanipulation (control)
Number of subjects: 30
Study: 22524350

Group type: EXPERIMENTAL
Intervention: Active participatory music class
Number of subjects: 100

Group type: COMPARATOR
Intervention: Passive music experience while playing
Number of subjects: 100
Study: 20103072

Group type: EXPERIMENTAL
Intervention: Nonphysician skills coach
Number of subjects: 49

Group type: COMPARATOR
Intervention: Faculty surgeon
Number of subjects: 49
Study: 18022319

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 405
Study: 16181233

Group type: EXPERIMENTAL
Intervention: 1 mg glucagon
Number of subjects: 9

Group type: COMPARATOR
Intervention: 1 ml saline
Number of subjects: 9
Study: 11562929

Group type: EXPERIMENTAL
Intervention: Individualized counseling from a genetic counselor
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Education from an interactive computer program followed by individualized counseling
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 9634323

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 lubricated condoms
Number of subjects: 635

Group type: COMPARATOR
Intervention: Plain silicone lubricated condoms
Number of subjects: 635
Study: 7875114

Group type: EXPERIMENTAL
Intervention: Hydroxyzine (50 mg/day)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 3349981

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atropine combined with Propranolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (without intervention)
Number of subjects: 11
Study: 31961377

Group type: EXPERIMENTAL
Intervention: Default quantities of opioids changed from 12 and 20 tablets to null, 5, 10, and 15 tablets.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Lower default quantities (e.g., 5 vs 15 tablets).
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Default settings in the EMR.
Number of subjects: 104
Study: 31336610

Group type: EXPERIMENTAL
Intervention: Technological integration methods
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Factors influencing technology integration
Number of subjects: 319
Study: 27473633

Group type: EXPERIMENTAL
Intervention: Morning light treatment (1 hour for 6 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Evening light treatment (1 hour for 6 days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both morning and evening light treatments
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Morning light treatment
Number of subjects: 10
Study: 26090395

Group type: EXPERIMENTAL
Intervention: Topical steroids and Meriva (curcumin) at 2 g per day for 12 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Topical steroids alone for 12 weeks
Number of subjects: 63
Study: 23852883

Group type: EXPERIMENTAL
Intervention: Suggestible participants
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Non-suggestible participants
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 129
Study: 21453658

Group type: EXPERIMENTAL
Intervention: Endoscopic approach
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 63
Study: 19540105

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg t.i.d.) + Vitamin E (100 mg t.i.d.)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo + Vitamin E (100 mg t.i.d.)
Number of subjects: 83